Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TTF-1 positive posterior pituitary tumor: Limitations of current treatment and potential new hope in BRAF V600E mutation variants.

Clinical neurology and neurosurgery - 1 Sept 2020

Dawoud Fakhry M, Naylor Ryan M, Giannini Caterina, Swanson Amy A, Meyer Fredric B, Uhm Joon H

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenoma, Oxyphilic
Share to Imidazoles
Share to Molecular Targeted Therapy
Share to Oximes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pituitary Neoplasms

Share to Pyridones

Share to Pyrimidinones

Share to Thyroid Nuclear Factor 1

Source

Identifiers

PMID: 32682222
DOI: 10.1016/j.clineuro.2020.106059

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TTF-1 positive posterior pituitary tumor: Limitations of current treatment and potential new hope in BRAF V600E mutation variants.PMID 32682222Read ↗

Dabrafenib monotherapy for a recurrent BRAFV600E-mutated TTF-1-positive posterior pituitary tumor.Semantic proximity Read ↗

Molecular therapy for papillary craniopharyngioma: a multi-institutional analysis of practice patterns across the RAPID Consortium.Semantic proximity Read ↗

[Histological Classification and Diagnosis of Sellar/Parasellar Tumors].Semantic proximity Read ↗

Immunotherapy in pituitary carcinomas and aggressive pituitary tumors.Semantic proximity Read ↗

Aggressive Pituitary TumorsSemantic proximity Read ↗

Future avenues in treatment of pituitary adenomas.Semantic proximity Read ↗

Transcription Factor–Based Classification of Pituitary Neuroendocrine Tumors: Practical Immunohistochemical Algorithms, Molecular Correlates, and Diagnostic Challenges in the 5th WHO EraSemantic proximity Read ↗

Validation of a Clinicopathological Classification for Predicting Outcomes of Pituitary Tumours: Retrospective Cohort Study in a Pituitary Tumour Centre of Excellence, 2013–2023Semantic proximity Read ↗

[Update Knowledge for Brain Tumors(10)Pituitary Adenoma].Semantic proximity Read ↗

Are PTTG1 variants associated with tumor characteristics and p53/Ki-67 expression in pituitary neuroendocrine tumors.Semantic proximity Read ↗

Subsequent Primary Malignancies in Patients with Initial Diagnosis of Pituitary Adenoma (Pit-NET): a Surveillance, Epidemiology, and End Results (SEER) Data AnalysisSemantic proximity Read ↗

Predictive Capacity of Mismatch Repair Status in the Use of Immune Checkpoint Inhibitors for the Treatment of Aggressive Pituitary Adenomas and Pituitary Carcinomas: Illustrative Case Report and Literature ReviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.